Online inquiry

IVTScrip™ mRNA-Human CD39, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK1603MR)

This product GTTS-WK1603MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the CD39 protein. This product can be used in -related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_001098175
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification oligo-dT affinity purification
Target Gene
Gene ID 953
UniProt ID P49961
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human CD39, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) (GTTS-WK1603MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK12401MR IVTScrip™ mRNA-Human ACAA1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ACAA1
GTTS-WK4184MR IVTScrip™ mRNA-Human CHST8, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA CHST8
GTTS-WK7518MR IVTScrip™ mRNA-Human AARS, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA AARS
GTTS-WK16901MR IVTScrip™ mRNA-Human ALDH3B1, (Cap 0, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA ALDH3B1
GTTS-WK9264MR IVTScrip™ mRNA-Human ADPRH, (Cap 0, Pseudo-UTP, 30 nt-poly(A)) mRNA ADPRH
GTTS-WK8806MR IVTScrip™ mRNA-Human ACAD8, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ACAD8
GTTS-WK18692MR IVTScrip™ mRNA-Human Aldehyde Dehydrogenase 1-A1, (Cap 1, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA Aldehyde Dehydrogenase 1-A1
GTTS-WK28759MR IVTScrip™ mRNA-Human ATG4B, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ATG4B
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW